Stocky
DXCM
DexCom, Inc.
NASDAQ · Healthcare · US
84.75
▲ +2.08%

Stocky turns companies like DexCom, Inc. into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →

What's happening at DexCom, Inc.

DexCom, Inc.'s latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 7 Aug 2026
Big update 30 Jul 2026

Reports second quarter 2026 financial results

Quarterly earnings show how the company is performing and growing its business.

SEC 10-Q · filed 2026-07-30 View filing ↗
Earnings 30 Jul 2026

Announces second quarter 2026 earnings results

Company releases quarterly financial results to investors on July 30, 2026.

SEC 8-K · filed 2026-07-30 View filing ↗
Governance 28 May 2026

Stockholders approve board director elections at annual meeting

Shareholders voted on company leadership; 336.5 million shares were represented.

SEC 8-K · filed 2026-05-28 View filing ↗
Money 15 May 2026

Authorizes one billion dollar stock buyback program

Company will repurchase up to $1.0 billion of its own stock through June 2027.

SEC 8-K · filed 2026-05-15 View filing ↗
Earnings 30 Apr 2026

Reports first quarter 2026 financial results

Quarterly earnings show company progress during the first three months of 2026.

SEC 10-Q · filed 2026-04-30 View filing ↗
Earnings 30 Apr 2026

Announces first quarter 2026 earnings results

Company releases quarterly financial results to investors on April 30, 2026.

SEC 8-K · filed 2026-04-30 View filing ↗
People 2 Mar 2026

Kevin Sayer transitions to Executive Chairman role

CEO Kevin Sayer retired January 1, 2026 and took Executive Chairman position.

SEC 8-K · filed 2026-03-02 View filing ↗

Common questions

How does Stocky track DexCom, Inc.'s company events?

Stocky reads DexCom, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was DexCom, Inc.'s most recent SEC filing?

DexCom, Inc.'s most recent tracked filing was a 10-Q on 30 Jul 2026: Reports second quarter 2026 financial results.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See DexCom, Inc. the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in DXCM would be worth today.
Practice portfolio
Buy DXCM with virtual money and track it — zero risk.
Free · no real money · learn by doing Open DXCM in Stocky →
See DexCom, Inc.'s full breakdown in Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 7 Aug 2026.